Odyssean LLC Purchases Shares of 3,398 Astera Labs, Inc. $ALAB

Odyssean LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,398 shares of the company’s stock, valued at approximately $1,641,000.

Several other hedge funds also recently modified their holdings of the company. Jupiter Topco LLC bought a new position in shares of Astera Labs in the second quarter valued at approximately $35,307,000. J. Goldman & Co LP bought a new stake in Astera Labs during the 2nd quarter worth approximately $324,000. ABS Investment Management LLC bought a new stake in Astera Labs during the 2nd quarter worth approximately $1,980,382,000. EFG International AG acquired a new stake in Astera Labs during the 2nd quarter valued at $23,883,000. Finally, Ancora Advisors LLC acquired a new stake in Astera Labs during the 2nd quarter valued at $155,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Activity

In other news, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total value of $4,047,300.00. Following the completion of the sale, the director directly owned 4,631 shares of the company’s stock, valued at approximately $2,083,950. This trade represents a 66.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 419,244 shares of company stock valued at $163,135,169. Insiders own 10.40% of the company’s stock.

Astera Labs Stock Up 1.8%

ALAB stock opened at $282.65 on Wednesday. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The company has a market cap of $49.04 billion, a P/E ratio of 139.93 and a beta of 3.84. The business’s fifty day moving average is $348.88 and its 200-day moving average is $247.38.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ALAB. Stifel Nicolaus lifted their price objective on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. Jefferies Financial Group raised their target price on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. UBS Group reiterated a “neutral” rating and set a $425.00 price target on shares of Astera Labs in a research report on Wednesday, August 5th. Rothschild & Co Redburn started coverage on shares of Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective for the company. Finally, Needham & Company LLC boosted their target price on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $333.00.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.